Profil
Gonzalo de Miquel is currently a Member-Supervisory Board at Ventaleon GmbH since 2017.
Previously, he worked as Director-Global Clinical Development at Almirall SA, Independent Director at ALK-Abello A, and Vice President-Clinical Development at AstraZeneca PLC.
He also served as Chief Medical Officer & Executive VP-Development at Vectura Group Ltd.
from 2017 to 2020.
Postes actifs de Gonzalo de Miquel
Sociétés | Poste | Début |
---|---|---|
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Director/Board Member | 12/10/2017 |
Anciens postes connus de Gonzalo de Miquel
Sociétés | Poste | Fin |
---|---|---|
VECTURA GROUP | Chief Tech/Sci/R&D Officer | 01/03/2020 |
ALK-ABELLÓ A/S | Director/Board Member | - |
ALMIRALL, S.A. | Corporate Officer/Principal | - |
ASTRAZENECA PLC | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
ALMIRALL, S.A. | Health Technology |
ALK-ABELLÓ A/S | Health Technology |
Entreprise privées | 2 |
---|---|
Vectura Group Ltd.
Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Health Technology |